Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,251.93
(
0.60%
)
US TECH 100
27,005.80
(
1.11%
)
Dow Jones
49,680.04
(
0.06%
)
Brent Oil
107.26
(
-2.80%
)
Bitcoin
78,597.36
(
2.97%
)
News Focus
News Focus
Post# of 257481
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11879
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: DewDiligence post# 203580

Thursday, 08/18/2016 6:38:09 AM

Thursday, August 18, 2016 6:38:09 AM

Post# of 257481
Auris Medical Reports Top-Line Results from TACTT2 Trial with Keyzilen in Acute Inner Ear Tinnitus

GlobeNewswire•August 18,2016

TACTT2 trial did not meet its co-primary efficacy endpoints

Top-line results from the Phase 3 TACTT3 trial expected in the fourth quarter of 2016

Second quarter 2016 financial results and conference call scheduled for today

http://finance.yahoo.com/news/auris-medical-reports-top-line-102517051.html
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today